Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1967 1
1968 1
1969 2
1973 2
1975 3
1976 6
1977 2
1978 2
1979 4
1980 1
1981 1
1982 3
1983 1
1984 2
1985 5
1986 1
1987 1
1988 5
1989 4
1990 5
1991 4
1992 5
1993 8
1994 6
1995 3
1996 4
1997 3
1998 6
1999 9
2000 4
2001 8
2002 7
2003 4
2004 8
2005 5
2006 14
2007 9
2008 9
2009 5
2010 11
2011 12
2012 5
2013 10
2014 8
2015 9
2016 15
2017 9
2018 13
2019 9
2020 11
2021 8
2022 8
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Jodele S, Dandoy CE, Lane A, Laskin BL, Teusink-Cross A, Myers KC, Wallace G, Nelson A, Bleesing J, Chima RS, Hirsch R, Ryan TD, Benoit S, Mizuno K, Warren M, Davies SM. Jodele S, et al. Blood. 2020 Mar 26;135(13):1049-1057. doi: 10.1182/blood.2019004218. Blood. 2020. PMID: 31932840 Free PMC article.
Subjects with higher complement activation measured by elevated blood sC5b-9 at the start of treatment were less likely to respond (odds ratio, 0.15; P = .0014) and required more doses of eculizumab (r = 0.43; P = .0004). Patients with intestinal bleeding had the fa …
Subjects with higher complement activation measured by elevated blood sC5b-9 at the start of treatment were less likely to respond (odds rat …
Obscure digestive bleeding.
Van Gossum A. Van Gossum A. Best Pract Res Clin Gastroenterol. 2001 Feb;15(1):155-74. doi: 10.1053/bega.2000.0161. Best Pract Res Clin Gastroenterol. 2001. PMID: 11355906 Review.
However, missed or underestimated upper and lower gastrointestinal lesions at the initial endoscopic investigation may be the source of a so-called obscure intestinal bleeding. The various radiological procedures, including enteroclysis, visceral angiography and CT …
However, missed or underestimated upper and lower gastrointestinal lesions at the initial endoscopic investigation may be the source of a so …
Drug-induced anaemias.
Girdwood RH. Girdwood RH. Drugs. 1976;11(5):394-404. doi: 10.2165/00003495-197611050-00003. Drugs. 1976. PMID: 782836 Review.
However, some substances, notably anticonvulsants, cause megaloblastic anaemia by some other mechanism. A number of drugs cause intestinal bleeding with anaemia as a result. Sideroblastic anaemia is a relatively rare condition, sometimes caused by drugs, particularl …
However, some substances, notably anticonvulsants, cause megaloblastic anaemia by some other mechanism. A number of drugs cause intestina …
Emicizumab for acquired haemophilia A: A case series.
Engelen MM, Vandesande J, De Bent J, Van Laer C, Labarque V, Jacquemin M, Peerlinck K, Hermans C, Verhamme P, Vanassche T. Engelen MM, et al. Haemophilia. 2023 Jul;29(4):1049-1055. doi: 10.1111/hae.14809. Epub 2023 Jun 5. Haemophilia. 2023. PMID: 37276345
AIMS: To report the clinical and biochemical response of emicizumab in AHA. METHODS: This single-centre retrospective study included seven adults with AHA between November 2020 and May 2022. ...RESULTS: Patients presented with spontaneous hematoma (n = 7), intramuscular bl …
AIMS: To report the clinical and biochemical response of emicizumab in AHA. METHODS: This single-centre retrospective study included …
Anticoagulation in atrial fibrillation. A large real-world update.
Bo M, Fumagalli S, Degli Esposti L, Perrone V, Dovizio M, Poli D, Marcucci R, Verdecchia P, Reboldi G, Lip GYH, Ungar A, Boccanelli A, Fumagalli C, Marchionni N; Italian Society of Geriatric Cardiology (SICGe). Bo M, et al. Eur J Intern Med. 2024 Mar;121:88-94. doi: 10.1016/j.ejim.2023.10.010. Epub 2023 Oct 23. Eur J Intern Med. 2024. PMID: 37879969 Free article.
We compared ischemic stroke (IS), IS and systemic embolism (IS/SE), intracranial hemorrhage (ICH), major bleeding (MB), major gastro-intestinal bleeding, all-cause deaths and the composite outcome, across four propensity-score matched treatment cohorts with >1540 …
We compared ischemic stroke (IS), IS and systemic embolism (IS/SE), intracranial hemorrhage (ICH), major bleeding (MB), major gastro-inte …
Proton pump inhibitors and clopidogrel: an association to avoid?
D'Ugo E, Rossi S, De Caterina R. D'Ugo E, et al. Intern Emerg Med. 2014 Feb;9(1):11-22. doi: 10.1007/s11739-013-1000-4. Epub 2013 Sep 13. Intern Emerg Med. 2014. PMID: 24030523 Review.
Dual antiplatelet therapy with aspirin and clopidogrel reduces cardiovascular events following an acute coronary syndrome or stent implantation, but the associated increased risk of gastro-intestinal bleeding often leads to the co-administration of proton pump inhib …
Dual antiplatelet therapy with aspirin and clopidogrel reduces cardiovascular events following an acute coronary syndrome or stent implantat …
Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
van Ginkel DJ, Bor WL, Veenstra L, van 't Hof AWJ, Fabris E. van Ginkel DJ, et al. Eur J Intern Med. 2022 Jul;101:14-20. doi: 10.1016/j.ejim.2022.05.002. Epub 2022 May 25. Eur J Intern Med. 2022. PMID: 35623935 Review.
Particularly, there is a considerable risk of ischaemic stroke and vascular access related bleeding, as well as spontaneous gastro-intestinal bleeding. Therefore, benefit and harm of antithrombotic therapy should be carefully balanced. ...
Particularly, there is a considerable risk of ischaemic stroke and vascular access related bleeding, as well as spontaneous gastro-intest …
Drug-disease interactions: narrative review of aspirin in gastric ulcer.
Nwose EU, Yee KC. Nwose EU, et al. Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):1081-7. doi: 10.1080/17425255.2016.1201064. Epub 2016 Jun 27. Expert Opin Drug Metab Toxicol. 2016. PMID: 27322160 Review.
For example, gastric ulcer has the potential to enhance absorption, bioavailability and therapeutic effects of aspirin, but this is rarely discussed in preference to the probability of gastro-intestinal bleeding side-effect....
For example, gastric ulcer has the potential to enhance absorption, bioavailability and therapeutic effects of aspirin, but this is rarely d …
Angiodysplasia of the colon in children.
de la Torre Mondragón L, Vargas Gómez MA, Mora Tiscarreño MA, Ramírez Mayans J. de la Torre Mondragón L, et al. J Pediatr Surg. 1995 Jan;30(1):72-5. doi: 10.1016/0022-3468(95)90614-2. J Pediatr Surg. 1995. PMID: 7722835 Review.
Angiodysplasia of the colon as a cause of lower intestinal bleeding is diagnosed frequently in the elderly, with defined clinical characteristics. ...Lower intestinal bleeding and severe anemia were present in all cases. The diagnosis and locali …
Angiodysplasia of the colon as a cause of lower intestinal bleeding is diagnosed frequently in the elderly, with defined cl …
Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials.
Vanassche T, Hirsh J, Eikelboom JW, Ginsberg JS. Vanassche T, et al. Thromb Haemost. 2014 Nov;112(5):918-23. doi: 10.1160/TH14-04-0346. Epub 2014 Sep 4. Thromb Haemost. 2014. PMID: 25187203 Review.
The development of non-VKA oral anticoagulants (NOACs), which inhibit either factor Xa or thrombin stoichiometrically, has provided alternatives to VKAs for several indications. The results of recent large-scale randomised controlled trials comparing NOACs with VKAs for th …
The development of non-VKA oral anticoagulants (NOACs), which inhibit either factor Xa or thrombin stoichiometrically, has provided alternat …
290 results